To prospectively compare the accuracy of high-spatialresolution steady-state magnetic resonance (MR) angiography with standard-resolution first-pass MR angiography in the lower extremities, with digital subtraction angiography (DSA) as the reference standard.
Institutional ethics committee approval and written informed consent were obtained. Twenty-seven patients (16 men, 11 women; mean age, 64.4 years Ϯ 14.8 [standard deviation]; range, 26 -87 years) suspected of having or known to have peripheral arterial disease underwent firstpass and steady-state MR angiography and DSA. Firstpass and steady-state MR angiography were performed in the same patient in the same session and with the same dose of blood pool contrast agent. The most severe stenosis grade of each evaluated segment was measured; sensitivity, specificity, and positive and negative predictive values were calculated at first-pass and steady-state MR angiography, with DSA as the reference standard. The coefficient was used to measure the agreement between first-pass MR angiography, steady-state MR angiography, and DSA.
Results:
A total of 334 arterial segments were available for intraindividual comparison of first-pass MR angiography, steady-state MR angiography, and DSA in 27 patients. In 20 (74%) of 27 patients, the stenosis grade of at least one of the evaluated vessels differed at steady-state MR angiography from that at first-pass MR angiography. In total, stenosis grade was judged as higher at first-pass MR angiography than at DSA (overestimation) in 28 of 334 segments and as lower (underestimation) in 15 of 334 segments. The stenosis grade as judged at steady-state MR angiography matched with that at DSA in 334 of 334 vessel segments.
Conclusion:
High-spatial-resolution steady-state MR angiography allowed for better agreement with DSA regarding stenosis grade in patients with arterial disease compared with standard-resolution arterial-phase first-pass MR angiography. RSNA, 2008 Supplemental material: http://radiology.rsnajnls.org/cgi /content/full/2492072033/DC1 T hree-dimensional (3D) contrast material-enhanced magnetic resonance (MR) angiography has become a routine application in the assessment of the vasculature in many regions of the body (1) (2) (3) . In patients with peripheral arterial occlusive disease, 3D contrast-enhanced MR angiography is an alternative to digital subtraction angiography (DSA), which still is considered the standard of reference (4) and is performed as the initial imaging study in many centers.
Standard gadolinium chelate contrast agents do not remain in the vascular lumen but rapidly extravasate into the interstitial space, which reduces intravascular contrast and therefore limits the maximum acquisition time for arterial imaging to the arterial bolus passage (5) . Therefore, 3D contrast-enhanced MR angiography has focused primarily on arterial imaging without venous enhancement, with a resultant inherent limitation in the maximum spatial resolution that can be obtained due to limited available acquisition time (6) (7) (8) (9) (10) .
New contrast agents that result in prolonged vascular contrast, blood pool contrast agents, were evaluated for 3D contrast-enhanced MR angiography (11, 12) . However, these studies focused on the comparison of blood pool contrast agent-enhanced 3D MR angiography with nonenhanced time-offlight MR angiography. As the first blood pool contrast agent, gadofosveset trisodium was approved for clinical application in the European Union. Gadofosveset trisodium reversibly binds to albumin, increasing T1 relaxivity (r1 ϭ 19 L ⅐ mmol Ϫ1 ⅐ sec Ϫ1 Ϯ 1 [standard deviation] at 1.5 T and 37°C in plasma; standard gadolinium chelate contrast agent, r1 ϭ 3.4-6.6 L ⅐ mmol Ϫ1 ⅐ sec
Ϫ1
) and extending vascular contrast enhancement during an equilibrium phase (steady state) that lasts for at least 1 hour (13) (14) (15) .
The extended available acquisition time with a blood pool contrast agent holds promise for acquisition of submillimetric 3D contrast-enhanced MR angiograms and therefore enhanced vascular delineation compared with that at standard-resolution 3D contrast-enhanced MR angiography. However, extended acquisition time during the steady state results in simultaneous enhancement of arteries and veins that may interfere with image interpretation. The purpose of this study was to prospectively compare the accuracy of high-spatial-resolution steady-state MR angiography with the blood pool contrast agent gadofosveset trisodium with standard-resolution first-pass MR angiography with the same blood pool contrast agent in the lower extremities, with DSA as the reference standard.
Materials and Methods
Only those authors who are not employees of Philips Medical Systems (Best, the Netherlands) had control of inclusion of any data and information that might present a conflict for the author (J.G.) who is an employee of this company. Prior to this study, Bayer Schering Pharma (Berlin, Germany) provided contrast medium for sequence optimization.
Patients
In a prospective, intraindividual comparison study, 27 
Advance in Knowledge
Ⅲ When compared with digital subtraction angiography (DSA), contrast-enhanced high-spatial-resolution steady-state MR angiography with a blood pool contrast agent resulted in increased sensitivity and specificity in the detection of significant stenosis of peripheral arteries of the lower extremities compared with those of standard-resolution first-pass MR angiography with a blood pool contrast agent. In eight patients, unilateral DSA was available for comparison with 3D contrast-enhanced MR angiographic results; this was because of former amputation of the other extremity in two patients and the need for onesided DSA after antegrade puncture in preparation for an interventional procedure in the other six patients. In one other case, a femoropopliteal bypass was performed after DSA and before 3D contrast-enhanced MR angiography. In this patient, the upper leg segments were excluded from the study. Figure 1 illustrates the study design. All patients were asked to report any adverse events and overall toleration of the procedure.
MR Imaging
Three-dimensional contrast-enhanced MR angiography was performed with a 1.5-T whole-body imager (Achieva; Philips Medical Systems) (maximum gradient amplitude, 33 mT/m; slew rate, 200 T/m/sec). A commercially available flexible four-channel phasedarray coil (Philips Medical Systems) was used for imaging the lower legs. Images of the upper legs and pelvic region were acquired with an integrated body coil. A biphasic injection protocol was implemented with automatic power injection (Spectris; Medrad Europe, Beek, the Netherlands) of contrast medium.
Gadofosveset trisodium (Vasovist; Bayer Schering Pharma) was injected at a flow rate of 1.2 mL/sec followed by a 25-mL saline flush at a flow rate of 0.6 mL/sec. First-pass MR angiography was initiated when the contrast medium reached the common iliac arteries as determined by using fluoroscopic triggering (17) .
Acquisition parameters for the coronal T1-weighted gradient-echo sequences during first-pass MR angiography and steady-state MR angiography are shown in Table 1 . The sequence flow is illustrated in Figure 2 .
Steady-state MR angiography was started in the same session as first-pass MR angiography with the same contrast medium after a delay of 4 minutes (18, 19) . First-pass MR angiographic native masks were electronically subtracted from contrast-enhanced firstpass MR angiographic acquisitions for reconstruction of maximum intensity projections.
Conventional Angiography
DSA is widely accepted as the standardof-reference procedure for the estimation of the grade of stenosis of diseased vessel segments in peripheral arterial occlusive disease (20) . DSA was performed by using a flat-panel C-arc angiographic unit (Allura Xper FD20; Philips Medical Systems). System detector size was 48 cm, field of view could be chosen from 15 to 48 cm, pixel size was 154 ϫ 154 m, and matrix was 2048 ϫ 2048.
A 5-F introducer sheath was placed in the common femoral artery, and a 5-F pigtail catheter was placed in the suprarenal abdominal aorta to obtain DSA series of pelvic and leg arteries. After the aortic bifurcation was located, the catheter was replaced to a position cephalad of the aortic bifurcation. Each series was obtained after administration of 20 -35 mL of contrast medium at 10 -12 mL/sec (iopamidol, Solutrast 300, 300 milligrams of iodine per milliliter; Altana Pharma, Konstanz, Germany). A total of 150 -190 mL of contrast medium was given for each examination, which consisted of six to eight series. In terms of single-sided angiography, an 18-gauge needle (or if before intervention, a 6-F introducer sheath) was placed antegrade in the common femoral artery. Four to five runs were achieved after manual delivery of 6 -15 mL of contrast medium per run, leading to a total of 42-65 mL of contrast medium.
Blood Pool Contrast Agent
Gadofosveset trisodium (Vasovist; Bayer Schering Pharma) is a gadolinium-based contrast agent with prolonged plasma half-life and increased relaxivity (r1 ϭ 19 L ⅐ mmol Ϫ1 ⅐ sec Ϫ1 Ϯ 1 at 1.5 T and 37°C in plasma) because of an additional diphenylcyclohexyl group that reversibly binds to plasma albumin (21) . Gadofosveset trisodium was applied at the recommended dosage of 0.03 mmol per kilogram of body weight in all patients (22) . The average total applied dose was 9.1 mL Ϯ 1.7 (range, 6 -14 mL).
Image Analysis
The Cases were reviewed in randomized order on a postprocessing workstation (Viewforum; Philips Medical Systems).
The readers used interactive reformation at the time of interpretation, including maximum intensity projections and multiplanar reformations.
The following segments were evaluated: aorta, iliac outflow (common iliac artery, external iliac artery, and common femoral artery), superficial femoral artery, popliteal artery, anterior tibial artery, tibial peroneal trunk, peroneal artery, and posterior tibial artery.
Maximum stenosis grade was measured as follows: The area of enhancing vessel lumen in a stenosed segment in a plane perpendicular to the track of the vessel (SL) was measured, as well as the area of the enhancing vessel lumen of the same vessel in a distal nonstenosed segment (NL) on first-pass and steadystate MR angiograms (23) (24) (25) . The grade of vessel stenosis was calculated as follows: (NL Ϫ SL)/NL. Cross-sectional stenosis measurement obtained in this manner has previously been shown to be a more accurate stenosis grading than with in-plane views (24, 26, 27) . Readers were asked to indicate whether or not venous enhancement interfered with image interpretation of arterial stenosis grading on steady-state MR angiograms. In addition, for visualization of stenosis grade, manual curved multiplanar reformations of the vessel of interest were reconstructed by following the centerline of the vessel (28) . The results of these measurements were evaluated according to the following scaling scheme: no significant stenosis (Ͻ50%), high-grade stenosis (Ն50%-99%), or occlusion (100%). A threshold of stenosis grade of 50% has previously been used as a primary efficacy variable in major trials for the detection of clinically relevant stenosis in peripheral arterial occlusive disease (11) (12) (13) 29, 30) . In all cases, a consensus opinion was reached without a discrepancy between the two readers with regard to grade of stenosis.
In a second step, the grade of steno- sis was evaluated by using DSA by one radiologist (K.W., 15 years of experience) who was not involved in the reading of 3D contrast-enhanced MR angiograms. The grade of stenosis of each vessel segment was evaluated by using the same scaling scheme for first-pass MR angiography, steady-state MR angiography, and DSA. To make sure that the same stenosis was taken for intermodality comparison, a fourth reader (J.B., 3 years of experience) compared the exact anatomic location of each stenosed vessel segment in patients with multiple stenosed vessel segments.
Statistical Analysis
For first-pass MR angiography, steadystate MR angiography, and DSA, 2 ϫ 2 contingency tables were plotted. Thresholds were set for determination of insignificant (Ͻ50%) versus significant (Ն50%) stenosis and of patency (Ͻ100%) versus occlusion (100%). The coefficient was used to measure agreement between first-pass MR angiography, steady-state MR angiography, and DSA. To account for the dependency of different measurements in the same patient, we first calculated per patient and then calculated an overall (31) . Sensitivity, specificity, and negative and positive predictive values, as well as their confidence limits, were calculated, with adjustment for the correlation between different measurements in the same patient by using generalized estimation equations. The estimated correlations were low (range, Ϫ0.020 to 0.062). All statistical analyses were performed with software (SPSS, version 14.0; SPSS, Chicago, Ill).
Results
First-pass and steady-state MR angiography were successfully performed in 27 of 27 patients. All patients tolerated the procedure well, and there were no adverse events. After exclusion of segments without DSA comparison, a total of 334 segments were available for intraindividual comparisons. All segments were satisfactorily visualized at firstpass and steady-state MR angiography. Both readers of steady-state MR angiograms independently indicated that the presence of veins on steady-state MR angiograms did not impair image interpretation in any of the 334 segments.
The grade of stenosis was judged as higher at first-pass MR angiography than at DSA in 28 (8.4%) of 334 segments (overestimation) (Fig 3 and 4 ; Fig  E1, http://radiology.rsnajnls.org/cgi /content/full/2492072033/DC3) and lower at first-pass MR angiography than at DSA in 15 (4.5%) of 334 segments (underestimation) (Fig 3, 4, 5 ; Table 2 ). Of the 10 segments that were considered to be occluded at first-pass MR angiography but not at DSA, six were judged as high-grade stenosis (Ն50%) at DSA and four as no relevant stenosis (Ͻ50%) at DSA. The grade of stenosis as judged with steady-state MR angiography matched the grade of stenosis with DSA in 334 (100%) of 334 segments. The grade of stenosis as judged with first-pass MR angiographic readings matched the stenosis grading with DSA in 291 (87.1%) of 334 segments.
In 39 (11.7%) of 334 segments, the stenosis grading at DSA differed from that at first-pass MR angiography by one grade; in four (1.2%) of 334 segments, the grading differed by two grades (occlusion vs nonstenosed segment) (Table  E1 , http://radiology.rsnajnls.org/cgi /content/full/2492072033/DC1). Twentysix (61%) of 43 segments with different grading at first-pass MR angiography and at DSA were located in lower leg segments, 14 (33%) of 43 segments were located in the upper leg segments, and three (7%) of 43 were located in the pelvis. In total, in 20 (74%) of 27 patients, the grade of stenosis of at least one of the patients' evaluated vessel segments was judged differently at firstpass MR angiography than at DSA. Tables 3 and 4 display the decision matrices (2 ϫ 2 contingency tables) for the comparison of the different modalities (first-pass MR angiography, steadystate MR angiography, and DSA) according to the thresholds of insignificant (Ͻ50%) versus significant (Ն50%) stenosis and patency (Ͻ100%) versus occlusion (100%).
For reporting of significant versus insignificant lesions, first-pass MR angiographic results showed a sensitivity of 82.1% (95% confidence interval [CI]: 72.9%, 88.7%), specificity of 91.0% (95% CI: 86.4%, 94.2%), positive predictive value of 75.4% (95% CI: 64.0%, 84.1%), and negative predictive value of 93.5% (95% CI: 88.3%, 96.5%). For the comparison of patent versus occluded segments at first-pass MR angiography, sensitivity of 100% (95% CI: 100%, 100%), specificity of 96.6% (95% CI: 93.3%, 98.3%), positive predictive value of 79.6% (95% CI: 66.6%, 88.5%), and negative predictive value of 100% (95% CI: 100%, 100%) were calculated. Because steady-state MR angiography and DSA stenosis grading matched in 334 (100%) of 334 segments, sensitivity, specificity, and positive and negative predictive values were 100% (95% CI: 100%, 100%) for both thresholds when these modalities were compared.
The overall coefficients that were 
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Discussion
First-pass MR angiography of the arteries of the lower extremities at standard spatial resolution with gadoliniumbased contrast agents is highly accurate in the assessment of stenosis grading compared with DSA (1, 20) and has been proposed as the first-line diagnostic tool in arterial vessel imaging (32) . Likewise, the intravascular contrast agent gadofosveset trisodium has been shown to allow for safe and effective MR angiographic studies during arterial bolus passage (11, 12) and to have at least as good of image quality as standard extracellular contrast agents at 3D contrast-enhanced MR angiography (33) . In addition to first-pass MR angiography, the application of gadofosveset trisodium allows for contrast enhancement during steady-state MR angiography with minimal decline in signal-and contrast-to-noise ratios, which allows for the application of longer 3D contrastenhanced MR angiographic sequences and thus the acquisition of higher resolution 3D contrast-enhanced MR angiograms of the vasculature (14) . The accuracy of stenosis grading from this steady state has been shown in preliminary studies (22, 34) . The ability to acquire steady-state MR angiograms of the lower extremities may markedly increase spatial resolution and diagnostic accuracy of MR angiography, but this has not yet been systematically examined. Because of simultaneous enhancement of arteries and veins, which is inherent to steady-state MR angiography, (f) Curved multiplanar reformation of high-spatial-resolution contrast-enhanced T1-weighted gradient-echo images (4.9/1.44) during the steady state. (g) Anterior view of selective DSA of right popliteal artery and proximal anterior tibial artery. Stenosis grade of right common femoral artery was judged as less than 50% on first-pass MR angiograms, but as 50% or higher on steady-state MR angiograms and DSA images (open arrow). Stenosis grade of right popliteal artery was judged as less than 50% on first-pass MR angiograms, but as 50% or higher on steady-state MR angiograms and DSA images (solid arrow). Note the better visualization of proximal right anterior tibial artery on steady-state MR angiograms than on DSA images (arrowhead). Stenosis grading of the latter segment was judged as 50% or higher on first-pass MR angiograms and less than 50% on steady-state MR angiograms and DSA images. maximum intensity projections are not adequate for image evaluation with steady-state MR angiography because of venous overlay. In multiplanar reformations, however, steady-state MR angiography at a resolution of 0.5 ϫ 0.5 ϫ 0.5 mm allows for the clear depiction of both arteries and veins without overlay, which allows for adequate stenosis grading of the enhanced artery despite simultaneously enhanced concomitant veins (35) .
The acquisition of high-spatialresolution steady-state MR angiographic studies is particularly useful in the evaluation of the grade of stenosis in the arteries of the lower legs and ankles. Patency of four segments at distant vessel levels of the peroneal artery was not demonstrated at first-pass MR angiography, whereas steady-state MR angiographic results revealed patency, with stenoses judged as less than 50%. In all four cases, DSA helped confirm the diagnosis obtained at steady-state MR angiography. First-pass MR angiography alone is often nondiagnostic in this region of the body because of early venous enhancement in patients with pedal ulcers or in a postsurgical state and because of the inability to differentiate arteries from veins with a resolution of 1 mm 3 that is typically acquired at standard-resolution first-pass MR angiography with gadolinium chelate contrast agent. One alternative to overcome this limitation is the acquisition of time-resolved MR angiographic studies of the lower legs (eg, time-resolved imaging of contrast kinetics, or TRICKS) in a hybrid approach with two separate injections (36) . This requires a high volume of contrast medium, which may be problematic, particularly for patients with impaired renal function who are at risk for nephrogenic systemic fibrosis. Even though no cases of nephrogenic systemic fibrosis have been reported after administration of gadofosveset trisodium so far, the total number of its applications worldwide is still small compared with traditional gadolinium chelate contrast agents, including gadopentetate dimeglumine (Magnevist; Bayer Schering Pharma) and gadodiamide (GE Healthcare, Princeton, NJ), and its potential risk for nephrogenic systemic fibrosis will need further investigation.
Additionally, even with the newest imager technology, with a hybrid approach, there is still a trade-off between temporal and spatial resolution, and it still may not be sufficient to achieve high diagnostic accuracy in all patients (37, 38) . A comparison of peripheral steady-state MR angiography and timeresolved MR angiography may be desirable in the future but was not the aim of the present study. Alternatively, the administration of tourniquets after application of blood pool contrast agent may be advantageous (39) .
The diameter of the vessels in the lower legs is particularly small (eg, 2.4 mm for the posterior tibial artery) (40) . Hoogeveen et al (41) have shown that at least 3 pixels are needed within the vascular lumen to assess the degree of stenosis with an error of less than 10%. Thus, to correctly judge the grade of stenosis in vessels as small as these, a submillimetric data set is highly desirable. Our results show that the agreement of stenosis grading at MR angiography and DSA is clearly improved with steady-state MR angiography. In renal arteries, it has been shown that lower spatial resolution may lead to both overand underestimation of the degree of stenosis (26) . We observed a similar trend of both over-and underestimation in the stenosis grading of peripheral arteries. Nevertheless, it may be advantageous to further increase spatial resolution and acquisition time of first-pass and steady-state MR angiography with the help of parallel imaging (35) . In addition, increased signal-to-noise ratio can be achieved by the application of large coil arrays and acquisition at higher field strengths (eg, 3.0 T), which in return may contribute to the use of high parallel-imaging acceleration factors that allow for further increase of spatial resolution and/or decrease of imaging time. Nikolaou et al (35) have recently shown that by the use of large coil arrays, spatial resolution of 0.5 ϫ 0.5 ϫ 0.5 mm can be achieved in all stations at peripheral MR angiography.
Our study had several limitations. First, the number of patients was limited, and future studies with larger study populations will be needed to increase statistical power. Second, the reading of steady-state MR angiograms was conducted in consensus by two radiologists because we wanted to conduct an intermodality comparison rather than an interobserver comparison. This may be beneficial in follow-up studies. Third, this study demonstrates the higher level of agreement of steadystate MR angiography with DSA but not the clinical effect on patient outcome. One can, however, assume that higher agreement between steady-state MR angiography and DSA may translate in improved selection of candidates for surgery or intervention on the basis of noninvasive steady-state MR angiography alone.
Fourth, while the standard of reference in clinical practice for stenosis grading still is widely accepted to be the measurement of percentage of diameter of stenosis on two-dimensional DSA images, cross-sectional measurement of percentage of area of stenosis has been shown to be more accurate at 3D contrast-enhanced MR angiography than percentage of diameter of stenosis measurement (24, 26, 27) . Nevertheless, we observed 100% agreement of DSA and steady-state MR angiographic readings in spite of the different measurement approaches. Although DSA is usually used as the standard of reference, it is known that DSA has some limitations (eg, evaluation of eccentric stenosis because no axial images are available in biplane DSA).
Finally, both first-pass and steadystate MR angiography were performed with the same injection of a blood pool contrast agent, whereas, as of to date, first-pass MR angiography in clinical practice is usually performed with a gadolinium chelate contrast agent. Prospective data are required that compare first-pass MR angiography with a gadolinium chelate contrast agent with firstpass and steady-state MR angiography with a blood pool contrast agent. However, Klessen et al (33) recently published results on the comparison of gadofosveset trisodium to a standard gadolinium chelate contrast agent at whole-body first-pass MR angiography and found first-pass MR angiography with a blood pool contrast agent to be of at least as good quality as that of firstpass MR angiography with a gadolinium chelate contrast agent. In addition, sen- sitivity, specificity, and positive and negative predictive values of first-pass MR angiography with gadofosveset trisodium reported in our study are in the range of those in the literature with a gadolinium chelate contrast agent (30) . Despite the limitations, the intraindividual study design with first-pass and steady-state MR angiography within the same session with one injection of a blood pool contrast agent may reduce variability between both examinations. Furthermore, it may be considered an advantage for clinical practice to perform both first-pass and steady-state MR angiography with a single injection of a blood pool contrast agent as it was done in our study design.
In clinical practice, we have therefore started to regard steady-state MR angiography as an add-on that may possibly increase diagnostic accuracy. We start the image interpretation procedure with standard-resolution arterialonly maximum intensity projections of subtracted first-pass MR angiographic data, because we regard the strength of first-pass MR angiographic acquisitions in the selection of nonstenosed arterial segments that do not need further interpretation at steady-state MR angiography. In a second step, we use steadystate MR angiographic acquisitions to specifically review segments of interest on higher resolution images with crosssectional and manual curved multiplanar reformations following the centerline of the vessel (28) . This combination of first-pass and steady-state MR angiographic acquisitions may allow for accelerated yet accurate stenosis grading. This, however, remains to be determined in future studies.
In conclusion, with DSA serving as the standard of reference, high-spatialresolution steady-state 3D contrast-enhanced MR angiography of the lower extremities with gadofosveset trisodium allowed for increased sensitivity and specificity in the detection of significant stenosis in patients with peripheral arterial occlusive disease compared with standard-resolution arterial-phase firstpass MR angiography with the same contrast agent. It remains to be investigated whether the increase in sensitivity and specificity that is achieved with steady-state MR angiography will translate into a therapeutic benefit for patients with peripheral arterial occlusive disease.
